Jacobs Levy Equity Management Inc. cut its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 15.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,421,237 shares of the company's stock after selling 252,981 shares during the quarter. Jacobs Levy Equity Management Inc. owned approximately 0.87% of Integral Ad Science worth $14,838,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of IAS. Alta Fox Capital Management LLC acquired a new stake in Integral Ad Science in the fourth quarter valued at $61,000. BNP Paribas Financial Markets bought a new stake in Integral Ad Science in the fourth quarter worth approximately $120,000. ClearAlpha Technologies LP acquired a new position in Integral Ad Science in the fourth quarter valued at approximately $143,000. PEAK6 LLC acquired a new position in shares of Integral Ad Science during the 4th quarter valued at $146,000. Finally, Handelsbanken Fonder AB bought a new position in shares of Integral Ad Science during the 4th quarter worth about $162,000. Institutional investors own 95.78% of the company's stock.
Wall Street Analysts Forecast Growth
IAS has been the subject of several recent research reports. Morgan Stanley decreased their price objective on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Baird R W downgraded shares of Integral Ad Science from a "strong-buy" rating to a "hold" rating in a report on Friday, March 28th. Scotiabank began coverage on shares of Integral Ad Science in a research report on Friday, February 28th. They set a "sector perform" rating and a $12.00 target price for the company. Truist Financial lifted their price target on Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a research note on Monday, March 3rd. Finally, Oppenheimer reissued an "outperform" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $13.55.
Get Our Latest Research Report on Integral Ad Science
Integral Ad Science Stock Performance
IAS stock traded up $0.05 during midday trading on Friday, hitting $8.09. The company's stock had a trading volume of 1,990,029 shares, compared to its average volume of 1,030,616. Integral Ad Science Holding Corp. has a 1 year low of $6.26 and a 1 year high of $13.62. The stock has a market cap of $1.33 billion, a price-to-earnings ratio of 40.45, a PEG ratio of 1.06 and a beta of 1.55. The stock's 50-day moving average price is $7.70 and its 200 day moving average price is $9.66. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company had revenue of $134.07 million for the quarter, compared to the consensus estimate of $129.20 million. On average, equities analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.
Insider Transactions at Integral Ad Science
In related news, CEO Lisa Utzschneider sold 8,547 shares of the business's stock in a transaction dated Monday, April 7th. The stock was sold at an average price of $6.85, for a total value of $58,546.95. Following the sale, the chief executive officer now directly owns 341,271 shares in the company, valued at approximately $2,337,706.35. The trade was a 2.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders sold a total of 86,222 shares of company stock worth $636,252 in the last quarter. Insiders own 2.00% of the company's stock.
Integral Ad Science Profile
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Recommended Stories

Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.